FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   Symphony Capital Partners LP 2. Date of Event Requiring Statement (Month/Day/Year) 12/30/2009 3. Issuer Name and Ticker or Trading Symbol DYNAVAX TECHNOLOGIES CORP [DVAX] (Last) (First) (Middle) 875 THIRD AVENUE, 3RD FLOOR 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director __X__ 10% Owner _____ Officer (give title below) __X__ Other (specify below) See Footnote 2 and Remarks 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) NEW YORK, NY 10022 6. Individual or Joint/Group Filing(Check Applicable Line) ___ Form filed by One Reporting Person _X_ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock, par value $0.001 per share 8,340,800 D (1) (2) Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Warrant (right to buy)	12/30/2009	12/30/2014	Common Stock	1,283,200	$ 1.94	D (2) (3)	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Symphony Capital Partners LP 875 THIRD AVENUE 3RD FLOOR NEW YORK, NY 10022	  X	  X	Â	See Footnote 2 and Remarks
SYMPHONY CAPITAL GP, L.P. 875 THIRD AVENUE 3RD FLOOR NEW YORK, NY 10022	  X	  X	Â	See Footnote 2 and Remarks
SYMPHONY GP, LLC 875 THIRD AVENUE 3RD FLOOR NEW YORK, NY 10022	  X	  X	Â	See Footnote 2 and Remarks
TARANTO HARRI V C/O SYMPHONY CAPITAL PATNERS, L.P. 875 THIRD AVENUE, 3RD FLOOR NEW YORK, NY 10022	  X	  X	Â	See Footnote 2 and Remarks
SYMPHONY STRATEGIC PARTNERS LLC 875 THIRD AVENUE 3RD FLOOR NEW YORK, NY 10022	  X	  X	Â	See Footnote 2 and Remarks

Signatures

/s/ Symphony Capital Partners, L.P., by Symphony Capital GP, L.P., its general partner, by Symphony GP, LLC, its general partner, by Mark Kessel, a managing member		01/11/2010
**Signature of Reporting Person		Date
/s/ Symphony Capital GP, L.P., by Symphony GP, LLC, its general partner, by Mark Kessel, a managing member		01/11/2010
**Signature of Reporting Person		Date
/s/ Symphony GP, LLC, by Mark Kessel, a managing member		01/11/2010
**Signature of Reporting Person		Date
/s/ Symphony Strategic Partners, LLC, by Mark Kessel, a managing member		01/11/2010
**Signature of Reporting Person		Date
/s/ Harri V. Taranto		01/11/2010
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Includes 7,910,764 shares of common stock directly owned by Symphony Capital Partners, L.P. ("SCP L.P.") and 430,036 shares of common stock directly owned by Symphony Strategic Partners, LLC ("Strategic Partners LLC").
(2)	Symphony GP, LLC ("SGP LLC") is the general partner of Symphony Capital GP, L.P. ("SC GP L.P."), which is the general partner of SCP L.P. Mark Kessel and Harri V. Taranto are managing members of SGP LLC and Strategic Partners LLC. Mr. Kessel is also a member of Dynavax Technologies Corporation's (the "Issuer") board of directors. As such, each of the reporting persons may be deemed to be a director of the Issuer by deputization.
(3)	Includes one warrant directly owned by SCP L.P. representing the right to purchase 1,217,040 shares of common stock and one warrant directly owned by Strategic Partners LLC representing the right to purchase 66,160 shares of common stock.
  Remarks: The reporting persons may be deemed to be a member of a "group" for purposes of the Securities Exchange Act of 1934, as  amended.  The reporting persons disclaim beneficial ownership of any securities deemed to be owned by the group that are not  directly owned by such reporting persons. This report shall not be deemed an admission that any reporting person is a member  of a group or the beneficial owner of any securities not directly owned by the reporting persons.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.